These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 921830)

  • 1. Levamisole in systemic lupus erythematosus.
    Smolen J; Scherak O; Menzel J; Kojer M; Kolarz G
    Arthritis Rheum; 1977; 20(8):1558-9. PubMed ID: 921830
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of levamisole (Decaris) on various immunologic parameters in patients with systemic lupus erythematosus].
    Gandzha IM; Sakharchuk VM; Lysenko GI
    Ter Arkh; 1981; 53(7):121-4. PubMed ID: 6457406
    [No Abstract]   [Full Text] [Related]  

  • 3. Levamisole in systemic lupus erythematosus.
    Ogawa K; Sano T; Hisano G; Tsubura E
    Ann Allergy; 1979 Sep; 43(3):187-9. PubMed ID: 314248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of levamisole on immunological parameters in patients with systemic lupus erythematosus.
    Scherak O; Smolen JS; Menzel EJ; Kojer M; Kolarz G
    Scand J Rheumatol; 1980; 9(2):106-12. PubMed ID: 6968971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Removal of a blocking factor from the sera of patients with systematic lupus erythematosus with Levamisole.
    Rosling AE; Rhodes EL; Watson B
    Clin Exp Dermatol; 1978 Mar; 3(1):39-42. PubMed ID: 348360
    [No Abstract]   [Full Text] [Related]  

  • 6. Levamisole in the treatment of systemic lupus erythematosus--preliminary results.
    Feng PH; Oon CJ; Yo SL; Lau YK
    Singapore Med J; 1978 Sep; 19(3):120-4. PubMed ID: 751195
    [No Abstract]   [Full Text] [Related]  

  • 7. [Levamisole and its effect on the E-rosette restoration test in healthy subjects and in systemic lupus erythematosus (author's transl)].
    Rovenský J; Pekárek J; Holt PJ; Mistina T; Zitnan D
    Cas Lek Cesk; 1981 Jun; 120(25):761-3. PubMed ID: 7260993
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunotherapy of lupus erythematosus].
    Glavinskaia TA; Kurnikov GIu; Pavlova LT
    Vestn Dermatol Venerol; 1982 Jul; (7):4-8. PubMed ID: 7136252
    [No Abstract]   [Full Text] [Related]  

  • 9. Levamisole treatment of systemic lupus erythematosus.
    Rovenský J; Cebecauer L; Zitnan D; Lukác J; Ferencík M
    Arthritis Rheum; 1982 Apr; 25(4):470-1. PubMed ID: 7073778
    [No Abstract]   [Full Text] [Related]  

  • 10. Study of lymphocyte subpopulations in patients with systemic lupus erythematosus. In vitro effect of levamisole on T-lymphocyte population.
    Pozsonyi T; Jakab L; Fehér J
    Allergol Immunopathol (Madr); 1980; 8(5):553-8. PubMed ID: 6970515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ineffectiveness of levamisole in systemic lupus erythematosus: a controlled trial.
    Hadidi T; Decker JL; El-Nagdy L; Samy M
    Arthritis Rheum; 1981 Jan; 24(1):60-3. PubMed ID: 7008800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter: Treatment of systemic lupus erythematosus with levamisole.
    Kassan SS
    Ann Allergy; 1976 Aug; 37(2):148-50. PubMed ID: 970682
    [No Abstract]   [Full Text] [Related]  

  • 13. [Our experiences with levamisole treatment in systemic lupus erythematosus (author's transl)].
    Rovenský J; Zitńan D; Cebecauer L; Lukác J
    Bratisl Lek Listy; 1981 May; 75(5):603-10. PubMed ID: 7016260
    [No Abstract]   [Full Text] [Related]  

  • 14. [Levamisole and heparin depot in the treatment of rapidly progressing glomerulonephritis in systemic lupus erythematosus].
    Klinger M; Klimkiewicz E
    Wiad Lek; 1978 Dec; 31(24):1743-6. PubMed ID: 735087
    [No Abstract]   [Full Text] [Related]  

  • 15. The treatment of systemic lupus erythematosus (SLE) with the T-cell immunostimulant drug levamisole: A case report.
    Gordon BL; Keenan JP
    Ann Allergy; 1975 Dec; 35(6):343-55. PubMed ID: 1081857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of levamisole in lupus nephritis].
    Horiuchi A
    Nihon Jinzo Gakkai Shi; 1979 Apr; 21(4):280-3. PubMed ID: 480701
    [No Abstract]   [Full Text] [Related]  

  • 17. Decreased lymphocyte response to PHA, Con-A, and calcium ionophore (A23187) in patients with RA and SLE, and reversal with levamisole in rheumatoid arthritis.
    Scheinberg MA; Santos L; Mendes NF; Musatti C
    Arthritis Rheum; 1978 Apr; 21(3):326-9. PubMed ID: 348204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis of T-immunodeficiencies in lupus erythematosus and patient treatment with levamisole].
    Shaposhnikov OK; Gorbunov VF
    Vestn Dermatol Venerol; 1979 Mar; (3):3-6. PubMed ID: 311566
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of systemic lupus erythematosus with the T-cell immunopotentiator levamisole: a follow-up report of 16 patients under treatment for a minimum period of four months.
    Gordon BL; Yanagihara R
    Ann Allergy; 1977 Oct; 39(4):227-36. PubMed ID: 71868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levamisole maintains cyclophsophamide-induced remission in murine lupus erythematosus.
    Zulman J; Michalski J; McCombs C; Greenspan J; Talal N
    Clin Exp Immunol; 1978 Feb; 31(2):321-7. PubMed ID: 306328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.